PixarBio Corporation (PXRB) 是一家上市公司 属于 非必需消费品 板块，经营于 Personal Products & Services 行业. 现任CEO为 Francis M. Reynolds.
PXRB 拥有 IPO日期为 2023-06-27, 30 名全职员工, 在 Other OTC, 市值为 $82.00.
PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company was founded in 2014 and is based in Medford, Massachusetts.
